Biblio
Export 1131 results:
Author [ Title
Filters: First Letter Of Last Name is D [Clear All Filters]
“Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?”, J Alzheimers Dis, vol. 63, no. 1, pp. 217-225, 2018.
, “Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention.”, J Alzheimers Dis, vol. 90, no. 3, pp. 989-992, 2022.
, “B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 3, pp. 1039-1055, 2021.
, “BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
, “BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
, “BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function.”, J Alzheimers Dis, vol. 55, no. 2, pp. 645-657, 2017.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”, J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”, J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “Behavioral Variant Frontotemporal Dementia Performance on a Range of Saccadic Tasks.”, J Alzheimers Dis, vol. 65, no. 1, pp. 231-242, 2018.
, “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
, “Benefits of Occupational Therapy in Dementia Patients: Findings from a Real-World Observational Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 509-517, 2017.
, “Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.”, J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
, “Bilingualism and Cognitive Decline: A Story of Pride and Prejudice.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1237-1239, 2017.
, “Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1657-1682, 2018.
, “Biochemical and Radiological Markers of Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
, “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
, “Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1113-1123, 2018.
, “Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.”, J Alzheimers Dis, vol. 55, no. 3, pp. 973-979, 2017.
, “Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
, “Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 87-92, 2018.
,